Unique ID issued by UMIN | UMIN000044450 |
---|---|
Receipt number | R000050485 |
Scientific Title | Traction method versus conventional endoscopic submucosal dissection for gastric epithelial neoplasms |
Date of disclosure of the study information | 2021/06/06 |
Last modified on | 2024/12/08 16:25:16 |
Traction method versus conventional endoscopic submucosal dissection for gastric
epithelial neoplasms
Traction method versus conventional endoscopic submucosal dissection for gastric
epithelial neoplasms
Traction method versus conventional endoscopic submucosal dissection for gastric
epithelial neoplasms
Traction method versus conventional endoscopic submucosal dissection for gastric
epithelial neoplasms
Japan |
Gastric epithelial neoplasia
Gastroenterology |
Malignancy
NO
To confirm the superiority of efficacy and safety of Endo Trac ESD to conventional ESD for patients with gastric epithelial neoplasia
Safety,Efficacy
Confirmatory
Phase III
ESD procedure time
1)ESD procedure time according to the proficiency of the operator(trainee or expert),tumor size ,the location of the lesion, the presence of ulcer findings and institutions
2)Equipping time of Endo Trac
3)Procedure time from starting traction by Endo Trac to complete
4)Clip slip-off rate during Endo Trac ESD ,number of Endo Trac used
5)Conversion rate
6)Traction-related damage rate to specimen
7)Histologic evaluation(en bloc resection rate, curative resection rate, depth of tumor ,size of specimen and tumor)
8)Adverse events
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Device,equipment |
Endo Trac ESD group
Conventional ESD group
20 | years-old | <= |
Not applicable |
Male and Female
1)over 20 years old
2)gastric epihelial tumor that is ESD-adaptive by endoscopy in accordance with the 2020 ESD/EMR guideline for gastric cancer
3)performance status 0-2
4)obtained written informed consent after appropriate explanation prior to study
1)tumor suspected of deep submucosal invasion
2)tumor diagnosed as not gastric epithelial tumor pathologically
3)whole invisible tumor
4)tumor crossing the esophagogastric junction or the pylorus ring
5)ESD management of over double tumor
6)history of gastrectomy or reconstructive surgery of the gastric tract
7)easy bleeding
8)using over two antiplatelet or an anticoagulant medication
9)severe disease in other organs by ASA classification over class 4
10)pregnancy
11)any other reasons for ineligibility to investigator judgement
150
1st name | Mikitaka |
Middle name | |
Last name | Iguchi |
Wakayama Medical University Hospital
Gastroenterology
641-8509
811-1 Kimiidera, Wakayama, Wakayama Prefecture , Japan
073-447-2300
mikitaka@wakayama-med.ac.jp
1st name | Jun |
Middle name | |
Last name | Kinoshita |
Wakayama Medical University Hospital
Gastroenterology
641-8509
811-1 Kimiidera, Wakayama, Wakayama Prefecture , Japan
073-447-2300
jun@wakayama-med.ac.jp
Wakayama Medical University
Wakayama Medical University
Local Government
Wakayama Medical University Hospital
811-1 Kimiidera, Wakayama, Wakayama Prefecture , Japan
073-447-2300
jun@wakayama-med.ac.jp
NO
和歌山県立医科大学附属病院
和歌山ろうさい病院
2021 | Year | 06 | Month | 06 | Day |
Published
150
Completed
2021 | Year | 04 | Month | 26 | Day |
2021 | Year | 04 | Month | 26 | Day |
2021 | Year | 06 | Month | 06 | Day |
2025 | Year | 07 | Month | 19 | Day |
2021 | Year | 06 | Month | 06 | Day |
2024 | Year | 12 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050485